In summary, the role of FoxO1 in B cell malignancies, such as BL, MCL, CLL, and BCP‐ALL, reveals a complex involvement in promoting cell survival, proliferation, and disease progression. This evidence concerns the gene FOXO1 and B-cell chronic lymphocytic leukemia.